These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7334143)

  • 1. Sedative-hypnotic tolerance testing and withdrawal comparing diazepam to barbiturates.
    Perry PJ; Stambaugh RL; Tsuang MT; Smith RE
    J Clin Psychopharmacol; 1981 Sep; 1(5):289-96. PubMed ID: 7334143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative/hypnotic dependence: patient stabilization, tolerance testing, and withdrawal.
    Perry PJ; Alexander B
    Drug Intell Clin Pharm; 1986; 20(7-8):532-7. PubMed ID: 2874971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the barbiturate abstinence syndrome.
    Sullivan JT; Sellers EM
    Med J Aust; 1986 Nov; 145(9):456-8. PubMed ID: 3773832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for treatment of barbiturate dependence.
    Smith DE; Wesson DR
    JAMA; 1970 Jul; 213(2):294-5. PubMed ID: 5467903
    [No Abstract]   [Full Text] [Related]  

  • 5. Abuse liability of barbiturates and other sedative-hypnotics.
    Morgan WW
    Adv Alcohol Subst Abuse; 1990; 9(1-2):67-82. PubMed ID: 2198786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of severity of acute withdrawal from diazepam in mice: commonality with ethanol and pentobarbital.
    Metten P; Crabbe JC
    Pharmacol Biochem Behav; 1999 Jul; 63(3):473-9. PubMed ID: 10418790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique.
    Robinson GM; Sellers EM; Janecek E
    Clin Pharmacol Ther; 1981 Jul; 30(1):71-6. PubMed ID: 7237901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra pars reticulata is crucially involved in barbiturate and ethanol withdrawal in mice.
    Chen G; Kozell LB; Buck KJ
    Behav Brain Res; 2011 Mar; 218(1):152-7. PubMed ID: 20974184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyridine-sensitive calcium channels and barbiturate tolerance and withdrawal.
    Rabbani M; Brown J; Butterworth AR; Little HJ
    Pharmacol Biochem Behav; 1994 Mar; 47(3):675-80. PubMed ID: 8208788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient diffuse cerebral hypoperfusion in Tc-99m HMPAO SPECT of the brain during withdrawal syndrome following acute barbiturate poisoning.
    Kamijo Y; Soma K; Kondo R; Ohwada T
    Vet Hum Toxicol; 2002 Dec; 44(6):348-50. PubMed ID: 12458639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection for pentobarbital withdrawal severity: correlated differences in withdrawal from other sedative drugs.
    Kliethermes CL; Metten P; Belknap JK; Buck KJ; Crabbe JC
    Brain Res; 2004 May; 1009(1-2):17-25. PubMed ID: 15120579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management.
    Sellers EM
    CMAJ; 1988 Jul; 139(2):113-20. PubMed ID: 2898972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome.
    Belknap JK
    Clin Toxicol; 1978; 12(4):427-34. PubMed ID: 26494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient barbiturate withdrawal using phenobarbital.
    Gray GR; Smith DE; Wesson DR; Sheppard CW
    Int J Addict; 1972; 7(1):17-26. PubMed ID: 5043836
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of clonidine and lofexidine for the treatment of barbiturate withdrawal in mice.
    Siegel EG; Bonfiglio JF; Ritschel WA; Fant W
    Vet Hum Toxicol; 1985 Dec; 27(6):503-5. PubMed ID: 4082462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study.
    Sullivan M; Toshima M; Lynn P; Roy-Byrne P
    Ann Clin Psychiatry; 1993 Jun; 5(2):123-8. PubMed ID: 8348204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral phenobarbital loading: a safe method of barbiturate and nonbarbiturate hypnosedative withdrawal.
    Janecek E; Kapur BM; Devenyi P
    CMAJ; 1987 Sep; 137(5):410-2. PubMed ID: 3621099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine antagonist, CGS-8216, in diazepam- or pentobarbital-dependent and non-dependent rats.
    McNicholas LF; Martin WR
    Drug Alcohol Depend; 1986 Jul; 17(4):339-48. PubMed ID: 3093182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication].
    Sarrecchia C; Sordillo P; Conte G; Rocchi G
    Ann Ital Med Int; 1998; 13(4):237-9. PubMed ID: 10349206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative-hypnotic drug withdrawal syndrome: recognition and treatment [digest].
    Santos C; Olmedo RE; Kim J
    Emerg Med Pract; 2017 Mar; 19(3 Suppl Points & Pearls):S1-S2. PubMed ID: 28745845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.